Stay updated on iCASP9 & ΔCD19 LT in Allo HCT Clinical Trial
Sign up to get notified when there's something new on the iCASP9 & ΔCD19 LT in Allo HCT Clinical Trial page.

Latest updates to the iCASP9 & ΔCD19 LT in Allo HCT Clinical Trial page
- Check6 days agoChange DetectedThe page's revision history was updated with a new entry (v3.3.4) and removal of the previous entry (v3.3.3).SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page history shows a new Revision: v3.3.3 added; the HHS Vulnerability Disclosure link was removed, and the previous Revision: v3.3.2 was deleted. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check56 days agoChange DetectedA new Study Record Version entry for Revision v3.3.2 was added, and the Revision v3.2.0 entry was removed.SummaryDifference0.1%

- Check63 days agoChange DetectedThe top banner about government funding and NIH operating status was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check77 days agoChange DetectedA new version entry is added to the Record History, with minor UI adjustments; no core study data were changed.SummaryDifference0.1%

- Check106 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference12%

Stay in the know with updates to iCASP9 & ΔCD19 LT in Allo HCT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the iCASP9 & ΔCD19 LT in Allo HCT Clinical Trial page.